biotechnology startup Curve Therapeutics, 40.5 million pounds received investment. The company’s A series investment round, Pfizer Ventures Managed by. In the investment tour of the UK-based company Columbus Venture Partners, British Patient Capital, Advent Life Sciences ve Epidarex Capital took place. Curve Therapeutics announced that it will use the new investment to improve R&D studies and marketing activities.
The company in 2019 Ali Tavassoli ve Simon Kerry It was put into operation by. Curve Therapeutics is developing fundamentally new and effective medicines. The company focuses on understanding the biochemical processes and cellular interactions that underlie diseases and developing drugs that can interfere with these processes.
In diseases like cancer, there are certain proteins that cause normal cells to grow and spread out of control. Curve Therapeutics’ technology is being used to develop drugs that allow treating such proteins directly inside the cell. These drugs stop or slow the growth and spread of cancer cells.
Another area Curve Therapeutics is working on is blocking the effect of a protein called ATIC, which plays an important role in various types of cancer. This protein controls a process that supports the proliferation and spread of cancer cells. The drugs developed by Curve Therapeutics prevent the growth of cancer cells by blocking the effect of this protein.
Every year to 734 thousand people cancer is diagnosed. Therefore, it is thought that Curve Therapeutics may offer new options in the treatment of challenging diseases such as cancer.
Source link: https://webrazzi.com/2024/02/27/ilac-kesfine-odaklanan-biyoteknoloji-girisimi-curve-therapeutics-40-5-milyon-pound-yatirim-aldi/